For first-time users, the published evidence base is strongest on topical at 1 to 2%
Doctors look for a doubling time of less than 72 hours for levels this low
The common clinical practice of administering injectable BPC-157 on a fasted stomach, or at minimum away from large meals, reflects general peptide pharmacokinetic principles rather than BPC-157-specific data
Underlying Health Conditions (e.g., Anemia, Fatigue Disorders) Conditions like pernicious anemia, chronic fatigue, fibromyalgia, or malabsorption issues (e.g., IBS, celiac) often require ongoing support
My expertise in IV therapy for anxiety comes from years of working with registered nurses to develop targeted nutrient formulations that address both the physical and emotional aspects of anxiety